We attempted to inactivate endopolygaolacturonase from Stereum purpureum (EndoPG) IV of identical origin by linking the pro-sequence of S. purpureum ProEndoPG I to the C-terminus. The recombinant ProEndoPG IV, expressed in Escherichia coli, had no polygalacturonase (PG) activity, but activity was acquired after partial degradation of the pro-sequence with V8 protease, as was the case for Pro-EndoPG I. These results indicate that the pro-sequence of ProEndoPG I can suppress the PG activity of EndoPG IV.
Endopolygalacturonase (EC 3.1.1.15) is an enzyme that hydrolyzes the -1,4 glycosidic bond in polygalacturonic acid. Stereum purpureum endopolygalacturonse has been identified as the substance responsible for the symptoms of silver-leaf disease in apples, caused by S. purpureum, a pathogenic fungus, producing the same symptoms as those in trees naturally infected with the fungus. [1] [2] [3] The ASP-4B isolate used produced four forms of the enzyme, EndoPG I, II, III, and IV, having different isoelectric points. 4) EndoPG I, which had the highest pI (pH 8.5) of the four, has been studied in detail because it is the major component, accounting for over 50% of the EndoPGs in the isolate. 3, 5) The primary structure of EndoPG I, deduced by cloning (accession no. AB232992), is 44 amino acid residues longer than the mature EndoPG I isolated from the culture filtrate. [6] [7] [8] These 44 amino acid residues are located in the C-terminal region of EndoPG I. This kind of sequence is lacking in EndoPG II, III, and IV from the same isolate (accession no. EndoPG II, AB549214; III, AB549215; IV, AB252456). 8, 9) Although the mature EndoPG I purified from the culture filtrate is approximately 43-50% homologous with other fungal endoPGs, 7) there is no homology to the 44 residues lacking in the C-terminal region. 10) We have designated the enzyme possessing the 44-residue C-terminal sequence ProEndoPG I to distinguish it from EndoPG I. 11) We expressed Pro-EndoPG I in Escherichia coli and examined its activity. It was found that it had no PG activity, but that PG activity was acquired after partial degradation of the pro-sequence with V8 protease. 11) These results suggest that the pro-sequence suppressed PG activity of EndoPG itself.
In this study, to clarify the function of the prosequence further, we attempted to express an inactive form of EndoPG IV in E. coli that does not exist in nature, and confirmed that the pro-sequence of ProEndoPG I suppressed the PG activity of EndoPG IV.
We tested the effect of linking the pro-sequence to the C-terminus of intact EndoPG IV, which has eight more C-terminal amino acid residues than mature EndoPG I (Fig. 1A) 9) without deleting the amino acid residues. We designated this recombinant form Pro-EndoPG IV.
E. coli JM109 was used as host for plasmid propagation. The E. coli transformants were cultured in LB medium containing 50 mg/mL of ampicillin. E. coli Rosetta-gami 2 (Novagen, Madison, WI) was used as host for the expression of Pro-EndoPG IV. The E. coli transformants were selected on LB plates containing 50 mg/mL of ampicillin and 34 mg/mL of chloramphenicol. For protein expression in E. coli, the pET-11b vector (Novagen) was selected. 12) All the synthetic oligonucleotides used in this study were purchased from Fasmac (Atsugi, Japan). Expression vector pET/Pro-EPGIV was constructed as follows: The EndoPG IV and the pro-sequence DNAs were amplified by polymerase chain reaction (PCR) using PrimeSTAR HS (Takara Bio, Otsu, Japan) and the oligonucleotide primers ( Table 1 ). The DNA sequence encoding mature EndoPG IV (amino acid residues 1-343) was amplified from a cDNA clone by PCR. The NdeI site and the sequence overlapping on the 3 0 side were linked to the 5 0 side of the EndoPG IV DNA and to the 3 0 side respectively. To prepare the DNA corresponding to the pro-sequence, PCR was carried out using template the Pro-EndoPG I cDNA linked to a His-tag and the BamHI site at the 3 0 terminus. The overlap-PCR protocol included four primers and two-step PCR procedures. The reverse primer of EndoPG IV and the forward primer of the prosequence contained the overlapping sequences. At the first step, two independent PCR products were prepared, and these were mixed and subjected to PCR. The procedure used for overlap-PCR is shown in Fig. 1B . About 1,200 bp of the PCR product was digested with NdeI and BamHI, and then ligated into the corresponding sites of pET-11b using Ligation high Ver. 2 (Toyobo, Osaka, Japan). The ligation product was then transformed into competent cells of E. coli JM109 and amplified. The DNA sequence of the insert was confirmed using an ABI PRISM 310 sequencer (Life Table 1 
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Fig. 2. SDS-PAGE of Pro-EndoPG IV Purified by Ni-Affinity Column Chromatography (A), and CD Spectra of Recombinant Pro-EndoPG IV and Recombinant Digested with V8 Protease (B).
A, Digestion of Pro-EndoPG was carried out by incubation for 3 h at 30 C with V8 protease (4 units). Proteins in the 12.5% polyacrylamide gel were stained by silver staining. Lanes: M, molecular weight marker; 1, purified recombinant Pro-EndoPG IV; 2, recombinant Pro-EndoPG I; 3, recombinant EndoPG IV; 4, Pro-EndoPG IV digested with V8 protease. B, EndoPGIV and Pro-EndoPGIV + V8 indicate recombinant EndoPG IV and recombinant Pro-EndoPG IV digested with V8 protease respectively. These recombinants were dialyzed against 10 mM acetate buffer (pH 5.0), and then diluted in the same buffer to 0.3 mg of protein/mL. CD spectra were measured with a Jasco J-720 spectrophotometer (Jasco, Tokyo, Japan) a 25 C in a cuvette with a 2-mm path length. Technologies Japan, Tokyo, Japan). EndoPG activity was determined as described previously. 13) The constructed expression vector of Pro-EndoPG IV, pET/ProEPGIV, was transformed into Rosetta-gami 2 by the heat-shock method. Rosetta-gami 2 was then cultured in LB medium containing 50 mg/mL of ampicillin and 34 mg/mL of chloramphenicol at 37 C with shaking, and when the absorbance of the medium at 600 nm was 0.5, IPTG was added. After culture for 25 h at 20 C, the bacterial cells were harvested, and suspended in lysis buffer (50 mM NaH 2 PO 4 , 300 mM NaCl, and 10 mM imidazole, pH 8.0) for sonication, and an extract was obtained by centrifigation. The extract was applied to a Ni-NTA column (Qiagen, Venlo, Netherlands), and eluted with 250 mM imidazole solution. The homogeneity of the recombinant form was verified by SDS-PAGE (Fig. 2A) . The molecular weight increased by several thousand, corresponding to the prosequence, in comparison with EndoPG IV. An assay of the purified Pro-EndoPG IV revealed no activity, as expected, due to suppression by the pro-sequence. The conformation was also examined by analysis of the CD spectrum. The spectrum of Pro-EndoPG IV digested with V8 protease matched that of recombinant EndoPG IV 9) (Fig. 2B) . The decrease in the molecular weight of the digested Pro-EndoPG was observed by SDS-PAGE, although the details of the cleavage site were unclear. The characteristic spectra of the Pro-forms might have reflected the effects of the pro-sequence. As a result of protease treatment, Pro-EndoPG IV acquired activity equivalent to that of Pro-EndoPG I. Thus, the prosequence of Pro-EndoPG I suppressed the activity of EndoPG IV. The specific activity of recombinant EndoPG IV was 282.1 units/mg, while that of ProEndoPG IV digested with V8 protease was 248.8 units/mg. We succeeded in suppressing the enzymatic activity by linking the pro-sequence of Pro-EndoPG I to the C-terminus of EndoPG IV with 72% homology for the amino acid sequences of mature EndoPG I. Since Pro-EndoPG IV was activated by deletion of the prosequence with the protease, active suppression was not due to an irreversible change in the conformation of EndoPG IV itself. Although the isoelectric points of EndoPG IV were considerably different from I (4.9 for IV and 8.5 for I), the 11 catalytic residues and three disulfide bonds were conserved. Hence a sufficient degree of active suppression of EndoPG IV by the prosequence was to be expected.
The 3D structures of the PGs archived in the carbohydrate-active enzyme database fold into a righthanded parallel-helix. 14) Although the homologies between S. purpureum EndoPG I and those of other fungi are 40-50%, all of the catalytic residues in the endoPGs reported to date are conserved. There are four disulfide bonds in the enzymes from the other fungi, as compared with only three for S. purpureum, which lacks the fourth C-terminal disulfide bond.
The pro-sequence consisting of 44 amino acid residues included 13 that are acidic, and there were no basic amino acids. These acidic amino acids can contribute greatly to the suppression of enzyme activity by forming ion bridges between the basic amino acids on the molecule surface. The characteristics of this prosequence suggest that it might be possible to control the activity of endoPGs from other sources.
